Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Differential engagement of ORAI1 and TRPC1 in the induction of vimentin expression by different stimuli.

Stewart TA, Azimi I, Marcial D, Peters AA, Chalmers SB, Yapa KTDS, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Lab Invest. 2019 Jun 26. doi: 10.1038/s41374-019-0280-3. [Epub ahead of print]

PMID:
31243341
2.

The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.

Roberts-Thomson SJ, Chalmers SB, Monteith GR.

Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8). pii: a035204. doi: 10.1101/cshperspect.a035204. Review.

PMID:
31088826
3.

ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses.

Azimi I, Milevskiy MJG, Chalmers SB, Yapa KTDS, Robitaille M, Henry C, Baillie GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Cancers (Basel). 2019 Feb 11;11(2). pii: E208. doi: 10.3390/cancers11020208.

4.

Calcium signalling and breast cancer.

So CL, Saunus JM, Roberts-Thomson SJ, Monteith GR.

Semin Cell Dev Biol. 2019 Oct;94:74-83. doi: 10.1016/j.semcdb.2018.11.001. Epub 2018 Nov 16. Review.

PMID:
30439562
5.

Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation.

Azimi I, Bong AH, Poo GXH, Armitage K, Lok D, Roberts-Thomson SJ, Monteith GR.

Cell Mol Life Sci. 2018 Dec;75(24):4525-4537. doi: 10.1007/s00018-018-2904-y. Epub 2018 Aug 13.

PMID:
30105615
6.

ORAI channels and cancer.

Chalmers SB, Monteith GR.

Cell Calcium. 2018 Sep;74:160-167. doi: 10.1016/j.ceca.2018.07.011. Epub 2018 Jul 31. Review.

PMID:
30086406
7.

Calcium signaling and the therapeutic targeting of cancer cells.

Bong AHL, Monteith GR.

Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1786-1794. doi: 10.1016/j.bbamcr.2018.05.015. Epub 2018 May 26. Review.

PMID:
29842892
8.

An SAR study of hydroxy-trifluoromethylpyrazolines as inhibitors of Orai1-mediated store operated Ca2+ entry in MDA-MB-231 breast cancer cells using a convenient Fluorescence Imaging Plate Reader assay.

Stevenson RJ, Azimi I, Flanagan JU, Inserra M, Vetter I, Monteith GR, Denny WA.

Bioorg Med Chem. 2018 Jul 23;26(12):3406-3413. doi: 10.1016/j.bmc.2018.05.012. Epub 2018 May 9.

PMID:
29776832
9.

Assessment of cytosolic free calcium changes during ceramide-induced cell death in MDA-MB-231 breast cancer cells expressing the calcium sensor GCaMP6m.

Bassett JJ, Bong AHL, Janke EK, Robitaille M, Roberts-Thomson SJ, Peters AA, Monteith GR.

Cell Calcium. 2018 Jun;72:39-50. doi: 10.1016/j.ceca.2018.02.003. Epub 2018 Mar 2.

PMID:
29748132
10.

Assessment of CXC ligand 12-mediated calcium signalling and its regulators in basal-like breast cancer cells.

Jamaludin SYN, Azimi I, Davis FM, Peters AA, Gonda TJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Oncol Lett. 2018 Apr;15(4):4289-4295. doi: 10.3892/ol.2018.7827. Epub 2018 Jan 19.

11.

Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels.

Yapa KTDS, Deuis J, Peters AA, Kenny PA, Roberts-Thomson SJ, Vetter I, Monteith GR.

Life Sci. 2018 Apr 1;198:128-135. doi: 10.1016/j.lfs.2018.02.030. Epub 2018 Feb 26.

PMID:
29496495
12.

An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells.

Kaemmerer E, Turner D, Peters AA, Roberts-Thomson SJ, Monteith GR.

J Pharmacol Toxicol Methods. 2018 Jul - Aug;92:13-19. doi: 10.1016/j.vascn.2018.02.005. Epub 2018 Feb 10.

PMID:
29438745
13.

Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells.

Azimi I, Petersen RM, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Sci Rep. 2017 Nov 9;7(1):15140. doi: 10.1038/s41598-017-15474-7.

14.

Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.

Peters AA, Jamaludin SYN, Yapa KTDS, Chalmers S, Wiegmans AP, Lim HF, Milevskiy MJG, Azimi I, Davis FM, Northwood KS, Pera E, Marcial DL, Dray E, Waterhouse NJ, Cabot PJ, Gonda TJ, Kenny PA, Brown MA, Khanna KK, Roberts-Thomson SJ, Monteith GR.

Oncogene. 2017 Nov 16;36(46):6490-6500. doi: 10.1038/onc.2017.234. Epub 2017 Jul 31.

PMID:
28759041
15.

TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.

Azimi I, Milevskiy MJG, Kaemmerer E, Turner D, Yapa KTDS, Brown MA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

J Cell Sci. 2017 Jul 15;130(14):2292-2305. doi: 10.1242/jcs.196659. Epub 2017 May 30.

16.

Genetically Encoded Calcium Indicators as Probes to Assess the Role of Calcium Channels in Disease and for High-Throughput Drug Discovery.

Bassett JJ, Monteith GR.

Adv Pharmacol. 2017;79:141-171. doi: 10.1016/bs.apha.2017.01.001. Epub 2017 Mar 6. Review.

PMID:
28528667
17.

The calcium-cancer signalling nexus.

Monteith GR, Prevarskaya N, Roberts-Thomson SJ.

Nat Rev Cancer. 2017 Jun;17(6):367-380. doi: 10.1038/nrc.2017.18. Epub 2017 Apr 7. Review.

PMID:
28386091
18.

Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.

Bong AHL, Monteith GR.

Int J Biochem Cell Biol. 2017 Jun;87:23-26. doi: 10.1016/j.biocel.2017.03.014. Epub 2017 Mar 20.

PMID:
28336365
19.

Evaluation of known and novel inhibitors of Orai1-mediated store operated Ca2+ entry in MDA-MB-231 breast cancer cells using a Fluorescence Imaging Plate Reader assay.

Azimi I, Flanagan JU, Stevenson RJ, Inserra M, Vetter I, Monteith GR, Denny WA.

Bioorg Med Chem. 2017 Jan 1;25(1):440-449. doi: 10.1016/j.bmc.2016.11.007. Epub 2016 Nov 7.

PMID:
27856238
20.

Plasma membrane ion channels and epithelial to mesenchymal transition in cancer cells.

Azimi I, Monteith GR.

Endocr Relat Cancer. 2016 Nov;23(11):R517-R525. Epub 2016 Sep 12. Review.

PMID:
27619258
21.

PMCA2 silencing potentiates MDA-MB-231 breast cancer cell death initiated with the Bcl-2 inhibitor ABT-263.

Curry M, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2016 Sep 30;478(4):1792-7. doi: 10.1016/j.bbrc.2016.09.030. Epub 2016 Sep 7.

PMID:
27613092
22.

GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses.

Lee EC, Davis-Poynter N, Nguyen CT, Peters AA, Monteith GR, Strounina E, Popat A, Ross BP.

Nanoscale. 2016 Sep 28;8(36):16192-6. doi: 10.1039/c6nr03878f. Epub 2016 Sep 7.

PMID:
27604476
23.

Differential effects of two-pore channel protein 1 and 2 silencing in MDA-MB-468 breast cancer cells.

Jahidin AH, Stewart TA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):731-736. doi: 10.1016/j.bbrc.2016.06.127. Epub 2016 Jun 25.

PMID:
27353380
24.

Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.

Stewart TA, Azimi I, Brooks AJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Int J Biochem Cell Biol. 2016 Jul;76:64-74. doi: 10.1016/j.biocel.2016.05.007. Epub 2016 May 7.

PMID:
27163529
25.

The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.

Peters AA, Milevskiy MJ, Lee WC, Curry MC, Smart CE, Saunus JM, Reid L, da Silva L, Marcial DL, Dray E, Brown MA, Lakhani SR, Roberts-Thomson SJ, Monteith GR.

Sci Rep. 2016 May 5;6:25505. doi: 10.1038/srep25505.

26.

The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer.

Pera E, Kaemmerer E, Milevskiy MJG, Yapa KTDS, O'Donnell JS, Brown MA, Simpson F, Peters AA, Roberts-Thomson SJ, Monteith GR.

Cancer Cell Int. 2016 Mar 31;16:24. doi: 10.1186/s12935-016-0299-0. eCollection 2016.

27.

Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Mol Oncol. 2016 Jan;10(1):166-78. doi: 10.1016/j.molonc.2015.09.006. Epub 2015 Sep 25.

28.

Sequence diversity and differential expression of major phenylpropanoid-flavonoid biosynthetic genes among three mango varieties.

Hoang VL, Innes DJ, Shaw PN, Monteith GR, Gidley MJ, Dietzgen RG.

BMC Genomics. 2015 Jul 30;16:561. doi: 10.1186/s12864-015-1784-x.

29.

Estrogen modulation properties of mangiferin and quercetin and the mangiferin metabolite norathyriol.

Wilkinson AS, Taing MW, Pierson JT, Lin CN, Dietzgen RG, Shaw PN, Gidley MJ, Monteith GR, Roberts-Thomson SJ.

Food Funct. 2015 Jun;6(6):1847-54. doi: 10.1039/c5fo00133a.

PMID:
25940566
30.

Essential role of Orai1 store-operated calcium channels in lactation.

Davis FM, Janoshazi A, Janardhan KS, Steinckwich N, D'Agostin DM, Petranka JG, Desai PN, Roberts-Thomson SJ, Bird GS, Tucker DK, Fenton SE, Feske S, Monteith GR, Putney JW Jr.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):5827-32. doi: 10.1073/pnas.1502264112. Epub 2015 Apr 20.

31.

A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.

Stewart TA, Azimi I, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):509-514. doi: 10.1016/j.bbrc.2015.01.141. Epub 2015 Feb 7.

PMID:
25666946
32.

Altered calcium signaling in cancer cells.

Stewart TA, Yapa KT, Monteith GR.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2502-11. doi: 10.1016/j.bbamem.2014.08.016. Epub 2014 Aug 20. Review.

33.

Targeting EMT in cancer: opportunities for pharmacological intervention.

Davis FM, Stewart TA, Thompson EW, Monteith GR.

Trends Pharmacol Sci. 2014 Sep;35(9):479-88. doi: 10.1016/j.tips.2014.06.006. Epub 2014 Jul 16. Review.

PMID:
25042456
34.

Prostate cancer cells alter the nature of their calcium influx to promote growth and acquire apoptotic resistance.

Monteith GR.

Cancer Cell. 2014 Jul 14;26(1):1-2. doi: 10.1016/j.ccr.2014.06.015.

35.

Consequences of activating the calcium-permeable ion channel TRPV1 in breast cancer cells with regulated TRPV1 expression.

Wu TT, Peters AA, Tan PT, Roberts-Thomson SJ, Monteith GR.

Cell Calcium. 2014 Aug;56(2):59-67. doi: 10.1016/j.ceca.2014.04.006. Epub 2014 May 9.

PMID:
24889371
36.

Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Azimi I, Roberts-Thomson SJ, Monteith GR.

Br J Pharmacol. 2014 Feb;171(4):945-60. doi: 10.1111/bph.12486. Review.

37.

Assessment of ORAI1-mediated basal calcium influx in mammary epithelial cells.

Ross DG, Smart CE, Azimi I, Roberts-Thomson SJ, Monteith GR.

BMC Cell Biol. 2013 Dec 20;14:57. doi: 10.1186/1471-2121-14-57.

38.

Phytochemical extraction, characterisation and comparative distribution across four mango (Mangifera indica L.) fruit varieties.

Pierson JT, Monteith GR, Roberts-Thomson SJ, Dietzgen RG, Gidley MJ, Shaw PN.

Food Chem. 2014 Apr 15;149:253-63. doi: 10.1016/j.foodchem.2013.10.108. Epub 2013 Nov 1.

PMID:
24295704
39.

Effects of differentiation on purinergic and neurotensin-mediated calcium signaling in human HT-29 colon cancer cells.

Chowdhury MA, Peters AA, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2013 Sep 13;439(1):35-9. doi: 10.1016/j.bbrc.2013.08.034. Epub 2013 Aug 17.

PMID:
23962427
40.

Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line.

Davis FM, Parsonage MT, Cabot PJ, Parat MO, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Cancer Cell Int. 2013 Jul 29;13(1):76. doi: 10.1186/1475-2867-13-76.

41.

Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.

Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW Jr, Goodhill GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Oncogene. 2014 May 1;33(18):2307-16. doi: 10.1038/onc.2013.187. Epub 2013 May 20.

42.

Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells.

Curry MC, Peters AA, Kenny PA, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2013 May 10;434(3):695-700. doi: 10.1016/j.bbrc.2013.04.015. Epub 2013 Apr 18.

PMID:
23602897
43.

NHERF-1 regulation of EGF and neurotensin signalling in HT-29 epithelial cells.

Kruger WA, Monteith GR, Poronnik P.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):568-73. doi: 10.1016/j.bbrc.2013.02.047. Epub 2013 Feb 26.

PMID:
23454118
44.

Mango (Mangifera indica L.) peel extract fractions from different cultivars differentially affect lipid accumulation in 3T3-L1 adipocyte cells.

Taing MW, Pierson JT, Shaw PN, Dietzgen RG, Roberts-Thomson SJ, Gidley MJ, Monteith GR.

Food Funct. 2013 Feb 26;4(3):481-91. doi: 10.1039/c2fo30224a.

PMID:
23295454
45.

Quality Use of Medicines--medication safety issues in naming; look-alike, sound-alike medicine names.

Ostini R, Roughead EE, Kirkpatrick CM, Monteith GR, Tett SE.

Int J Pharm Pract. 2012 Dec;20(6):349-57. doi: 10.1111/j.2042-7174.2012.00210.x. Epub 2012 May 18. Review.

PMID:
23134093
46.

Calcium channels and pumps in cancer: changes and consequences.

Monteith GR, Davis FM, Roberts-Thomson SJ.

J Biol Chem. 2012 Sep 14;287(38):31666-73. doi: 10.1074/jbc.R112.343061. Epub 2012 Jul 20. Review.

47.

Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.

Peters AA, Simpson PT, Bassett JJ, Lee JM, Da Silva L, Reid LE, Song S, Parat MO, Lakhani SR, Kenny PA, Roberts-Thomson SJ, Monteith GR.

Mol Cancer Ther. 2012 Oct;11(10):2158-68. doi: 10.1158/1535-7163.MCT-11-0965. Epub 2012 Jul 17.

48.

Distinct regulation of cytoplasmic calcium signals and cell death pathways by different plasma membrane calcium ATPase isoforms in MDA-MB-231 breast cancer cells.

Curry MC, Luk NA, Kenny PA, Roberts-Thomson SJ, Monteith GR.

J Biol Chem. 2012 Aug 17;287(34):28598-608. doi: 10.1074/jbc.M112.364737. Epub 2012 Jun 25.

49.

Mango fruit peel and flesh extracts affect adipogenesis in 3T3-L1 cells.

Taing MW, Pierson JT, Hoang VL, Shaw PN, Dietzgen RG, Gidley MJ, Roberts-Thomson SJ, Monteith GR.

Food Funct. 2012 Aug;3(8):828-36. doi: 10.1039/c2fo30073g. Epub 2012 Jun 15.

PMID:
22699857
50.

Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry.

Davis FM, Peters AA, Grice DM, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR.

PLoS One. 2012;7(5):e36923. doi: 10.1371/journal.pone.0036923. Epub 2012 May 30.

Supplemental Content

Loading ...
Support Center